Arndt Vogel: The use of immunotherapy pre-liver transplant
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared a recent article by him and colleagues on X:
“Hot off the press: The use of immunotherapy pre-liver transplant in Journal of Hepatology.
- Hepatology Snapshot.
- Our thoughts on the use of ICI before liver transplant in HCC.
- Food for thoughts.”
“The use of immunotherapy pre-liver transplant“
Authors: Laia Aceituno, Annabel Katherine Gravely, Grainne Mary O’Kane, Arndt Vogel, and Gonzalo Sapisochin
Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer.
He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.
More posts featuring Arndt Vogel.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023